Carlisle
DM, Leape LL, Bickel S, Bell R, Kamberg C, Genovese B, French WJ, Kaushik
VS, Mahrer PR, Ellestad MH, Brook RH, Shapiro MF.
Underuse and overuse of diagnostic testing for coronary artery disease
in patients presenting with new-onset chest pain.
Am J Med 1999;106(4):391-8. (Comment in: Am J Med 1999;106(4):484-5).
Appropriateness and necessity criteria developed based on the RAND expert
panel method were employed to determine underuse and overuse of diagnostic
procedures for patients presenting with chest pain not due to myocardial
infarction in one of five urban hospital emergency departments in Los
Angeles. The sample included a large number of HMO patients. For the purpose
of this study, a diagnostic test was deemed inappropriate if "the
benefits did not outweigh the inherent risks," and necessity was
defined "as the obligation of a physician to recommend diagnostic
testing for coronary artery disease because it has a high probability
of significance." "Underuse" was therefore defined as the
"failure to provide diagnostic testing for coronary artery disease
for a patient with a necessary indication." "Overuse" was
the "provision of diagnostic testing for coronary artery disease
when the indication was inappropriate." Participants were mailed
a questionnaire four weeks after their presentation at the hospital. The
survey included questions on patient demographics and whether patients
received diagnostic procedures for coronary artery disease, as well as
the type of procedure received.
Among the 181 patients who met the necessity criteria for diagnostic
cardiac testing, 40 patients (22%) did not receive the necessary testing.
Lower patient education was found to be the only significant predictive
variable for this underuse. However, race was also associated with underuse
of diagnostic testing. The rates were higher among African- Americans
and Latinos in comparison to whites but lower among Asians and Pacific-Islanders;
these differences were not statistically significant.
The results of this study have important implications. Most studies to
date had examined racial differences in therapeutic cardiac care. Assessing
the disparities at the diagnostic stage would reveal a larger problem
because it is at this stage that a “therapeutic cascade” can
be triggered. Underuse of diagnostic procedures could lead to inaccurate
assessment of severity of disease, which would then further contribute
to the underuse of appropriate and necessary therapeutic procedures and
surgery.
Furthermore, the findings that “lower educational level may be a
proxy for the difficulty that patients have in paying for health care,
including diagnostic testing” and that “it may also be a marker
for other factors associated with testing, such as income, understanding
of complicated medical conditions, and access to alternative provider
opinions, legal interventions, or appeal processes” suggest “that
universal health insurance may not eliminate disparities in use of health-care
services related to socio-economic status.” In sum, the “findings
underscore the failure of the US health-care system to ensure the provision
of medical care for all patients who may need it.”
A potential limitation of this study is the high rate of loss of subjects
in follow-up. Of those subjects able to be contacted, only 63% consented
to participate in the study. Hence the final study sample of 356 may be
unrepresentative.